1. Home
  2. DNA vs TRTX Comparison

DNA vs TRTX Comparison

Compare DNA & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • TRTX
  • Stock Information
  • Founded
  • DNA 2008
  • TRTX 2014
  • Country
  • DNA United States
  • TRTX United States
  • Employees
  • DNA 834
  • TRTX N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • TRTX Real Estate Investment Trusts
  • Sector
  • DNA Health Care
  • TRTX Real Estate
  • Exchange
  • DNA Nasdaq
  • TRTX Nasdaq
  • Market Cap
  • DNA 731.1M
  • TRTX 715.2M
  • IPO Year
  • DNA N/A
  • TRTX 2017
  • Fundamental
  • Price
  • DNA $12.42
  • TRTX $9.30
  • Analyst Decision
  • DNA Hold
  • TRTX Buy
  • Analyst Count
  • DNA 2
  • TRTX 2
  • Target Price
  • DNA $9.50
  • TRTX $9.50
  • AVG Volume (30 Days)
  • DNA 1.6M
  • TRTX 490.1K
  • Earning Date
  • DNA 08-07-2025
  • TRTX 10-28-2025
  • Dividend Yield
  • DNA N/A
  • TRTX 10.38%
  • EPS Growth
  • DNA N/A
  • TRTX N/A
  • EPS
  • DNA N/A
  • TRTX 0.65
  • Revenue
  • DNA $230,815,000.00
  • TRTX $138,587,000.00
  • Revenue This Year
  • DNA N/A
  • TRTX N/A
  • Revenue Next Year
  • DNA $13.73
  • TRTX $6.91
  • P/E Ratio
  • DNA N/A
  • TRTX $14.23
  • Revenue Growth
  • DNA 25.21
  • TRTX 216.02
  • 52 Week Low
  • DNA $5.00
  • TRTX $6.47
  • 52 Week High
  • DNA $16.85
  • TRTX $9.36
  • Technical
  • Relative Strength Index (RSI)
  • DNA 49.28
  • TRTX 64.03
  • Support Level
  • DNA $11.92
  • TRTX $9.18
  • Resistance Level
  • DNA $12.81
  • TRTX $9.36
  • Average True Range (ATR)
  • DNA 0.99
  • TRTX 0.15
  • MACD
  • DNA -0.13
  • TRTX -0.01
  • Stochastic Oscillator
  • DNA 38.37
  • TRTX 82.61

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: